comparemela.com

Latest Breaking News On - Integer daily - Page 1 : comparemela.com

Scout Investments Inc Sells 1,584 Shares of Integer Holdings Co (NYSE:ITGR)

Scout Investments Inc. lowered its position in shares of Integer Holdings Co. (NYSE:ITGR – Free Report) by 1.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 100,749 shares of the medical equipment provider’s stock after selling 1,584 shares during the quarter. Scout Investments Inc. […]

Insider Selling: Integer Holdings Co (NYSE:ITGR) Director Sells $1,175,791 32 in Stock

Integer Holdings Co. (NYSE:ITGR – Get Free Report) Director James F. Hinrichs sold 9,603 shares of the company’s stock in a transaction that occurred on Friday, May 24th. The shares were sold at an average price of $122.44, for a total value of $1,175,791.32. Following the completion of the sale, the director now owns 7,424 […]

Integer Holdings Co (NYSE:ITGR) Director Sells $1,175,791 32 in Stock

Integer Holdings Co. (NYSE:ITGR – Get Free Report) Director James F. Hinrichs sold 9,603 shares of Integer stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $122.44, for a total value of $1,175,791.32. Following the completion of the transaction, the director now directly owns 7,424 shares of […]

Integer (NYSE:ITGR) Price Target Raised to $124 00 at Citigroup

Integer (NYSE:ITGR – Free Report) had its target price upped by Citigroup from $118.00 to $124.00 in a research report sent to investors on Wednesday morning, Benzinga reports. They currently have a neutral rating on the medical equipment provider’s stock. A number of other research firms have also recently issued reports on ITGR. Bank of […]

Integer (NYSE:ITGR) PT Raised to $124 00 at Citigroup

Integer (NYSE:ITGR – Free Report) had its target price boosted by Citigroup from $118.00 to $124.00 in a research report report published on Wednesday morning, Benzinga reports. Citigroup currently has a neutral rating on the medical equipment provider’s stock. Other equities research analysts have also issued research reports about the stock. Benchmark restated a buy […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.